| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Patusky Christopher is a Director at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 22 sells.
Estimated insider holdings value: $813K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | UTHR United Therapeutics Corp | Director | Sale+OE | 1,000 | $495.95 | $495,953.90 | -40.2% | +6.8% | - | |
| Mar 19, 2025 | UTHR United Therapeutics Corp | Director | Sale+OE | 5,000 | $310.72 | $1,553,584.58 | -19.9% | -10.0% | +65.3% | |
| Jan 10, 2025 | UTHR United Therapeutics Corp | Director | Sale+OE | 5,000 | $361.61 | $1,808,071.86 | -21.1% | -23.6% | +32.4% | |
| Sep 4, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 5,000 | $354.33 | $1,771,647.38 | -73.5% | +4.4% | +7.7% | |
| Jun 17, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 2,000 | $295.50 | $591,000.00 | -100% | +16.1% | -3.4% | |
| May 14, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 1,310 | $264.35 | $346,298.50 | -100% | +23.7% | +11.1% | |
| Feb 23, 2024 | UTHR United Therapeutics Corp | Director | Sell | 1,680 | $224.00 | $376,320.00 | -99.8% | +21.8% | +59.1% | |
| Nov 17, 2022 | UTHR United Therapeutics Corp | Director | Sale+OE | 100 | $262.61 | $26,261.00 | -8.3% | -4.3% | -13.5% | |
| Nov 8, 2021 | UTHR United Therapeutics Corp | Director | Sell | 2,300 | $200.16 | $460,368.00 | -57.8% | -1.1% | +30.1% | |
| May 10, 2021 | UTHR United Therapeutics Corp | Director | Sale+OE | 100 | $190.52 | $19,052.00 | -7.7% | +9.4% | -5.7% |